Development, validation and clinical implementation of a UPLC-MS/MS bioanalytical method for simultaneous quantification of cabotegravir and rilpivirine E-isomer in human plasma.
Saved in:
| Title: | Development, validation and clinical implementation of a UPLC-MS/MS bioanalytical method for simultaneous quantification of cabotegravir and rilpivirine E-isomer in human plasma. |
|---|---|
| Authors: | Bevers LAH; Department of Pharmacy & Radboudumc Institute for Medical Innovation (RIMI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. Electronic address: Lisanne.Bevers@radboudumc.nl., van Ewijk-Beneken Kolmer EWJ; Department of Pharmacy & Radboudumc Institute for Medical Innovation (RIMI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands., Te Brake HML; Department of Pharmacy & Radboudumc Institute for Medical Innovation (RIMI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands., Burger DM; Department of Pharmacy & Radboudumc Institute for Medical Innovation (RIMI), Radboud University Medical Center, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. |
| Source: | Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Jan 20; Vol. 238, pp. 115832. Date of Electronic Publication: 2023 Nov 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-264X |
|---|---|
| DOI: | 10.1016/j.jpba.2023.115832 |